MD (Pediatrix Medical Group, Inc.) Stock Financials & Earnings

MDPediatrix Medical Group, Inc.

Mkt Cap$2B

Revenue (TTM)$1.9B

Net Income (TTM)$165M

EPS (TTM)$1.93

Free Cash Flow (TTM)$253M

Gross Margin25.5%

Op. Margin11.2%

Net Margin8.6%

FCF Margin13.2%

P/S Ratio (TTM)0.9x

P/E Ratio (TTM)10.5x

YoY Rev Growth-4.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$491M	$98M	$30M
Q2 23	$501M	$115M	$48M
Q3 23	$507M	$107M	$40M
Q4 23	$496M	$101M	-$111M
Q1 24	$495M	$95M	$16M
Q2 24	$504M	$114M	-$158M
Q3 24	$511M	$117M	$34M
Q4 24	$502M	$129M	$39M
Q1 25	$458M	$103M	$32M
Q2 25	$469M	$125M	$60M
Q3 25	$493M	$140M	$68M
Q4 25	$494M	$120M	$55M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Health Care, Patient Service	Hospitals Contracts	Product and Service, Other
Q1 23	$423M	$66M	$2M
Q2 23	$430M	$70M	$609K
Q3 23	$437M	$69M	$579K
Q4 23	$425M	$71M	—
Q1 24	$422M	$72M	$1M
Q2 24	$433M	$71M	$536K
Q3 24	$439M	$72M	$70K
Q4 24	$430M	$72M	$558K
Q1 25	$389M	$65M	$4M
Q2 25	$397M	$68M	$3M
Q3 25	$422M	$68M	$3M
Q4 25	$422M	$70M	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$6M	$97M	$103M
Q2 23	$6M	$98M	$104M
Q3 23	$21M	$104M	$125M
Q4 23	$73M	$104M	$178M
Q1 24	$8M	$107M	$115M
Q2 24	$19M	$114M	$133M
Q3 24	$104M	$117M	$220M
Q4 24	$230M	$119M	$349M
Q1 25	$99M	$120M	$219M
Q2 25	$225M	$124M	$348M
Q3 25	$340M	$123M	$463M
Q4 25	$375M	$124M	$500M

Shares Outstanding

Revenue Per Employee

Revenue / Employee